Clinical Trials for Rosacea
Clinical trials are research studies conducted in an effort to improve overall patient health and care.
Each trial involves running supervised tests to determine the effectiveness and safety of new drugs, procedures and/or devices with the aim of answering scientific questions about a disease or condition.
Risks and side-effects are also evaluated during these trials with results ranging from being unpleasant, with side effects such as headaches, to more serious or even life-threatening risks.
A clinical trial may be separated into phases, or steps, with each step designed to answer a separate research question. This maybe reflected in the trial name.
A brief description of each phase:
- Phase I: Usually designed to evaluate safety, determine a safe dosage range, and identify side effects on a small group of patients.
- Phase II: If Phase I is successful, the trial is then repeated with a larger group to further evaluate its effect and safety.
- Phase III: Trials are conducted on an ever larger group and are compared with the best current treatment while gathering more information on effect and safety.
- Phase IV: These studies monitor long-term side effects after the treatment has been marketed.
Clinical Trials data for Rosacea is grouped into the following categories:-
The format for each of the following is:
- The name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
- followed by a list of drug/s, if any, used in the trial
ClinicalTrials.gov has listed the following trials for Rosacea:
- A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea - This study has been completed (Current: 23 Nov 2006) - doxycycline
- A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006) - Vehicle control, 2x/day,ACZONE (dapsone) Gel, 5%, 2x/day,ACZONE (dapsone) Gel, 5%, 1x/day,MetroGel® (metronidazole gel), 1.0% 1x/day,ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM)
- Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial - This study is currently recruiting patients (Current: 23 Nov 2006) - Zinc Sulfate or placebo
- Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea - This study has been completed (Current: 23 Nov 2006) - doxycycline hyclate 20 mg twice daily
- Topical Agent for Treatment of Red Skin - This study is currently recruiting patients (Current: 23 Nov 2006) - Investigational Topical Agent
- Efficacy of Topical Cyclosporin for Ocular Rosacea - This study is currently recruiting patients (Current: 23 Nov 2006) - Cyclosporin 0.05% Ophthalmic Solution
The format for each of the following is:
- The drug,
- followed by the name of the trial,
- followed by whether the trial is recruiting patients,
- The trial may not have started and not yet recruiting, or the trial may have started and do not need any more recruitements, or the trial may be completed.
- Note**: Please follow the link to determine the current trial status.
ClinicalTrials.gov has listed the following drugs in trials for Rosacea:
- ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM) - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
- ACZONE (dapsone) Gel, 5%, 1x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
- ACZONE (dapsone) Gel, 5%, 2x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
- Cyclosporin 0.05% Ophthalmic Solution - Efficacy of Topical Cyclosporin for Ocular Rosacea - This study is currently recruiting patients (Current: 23 Nov 2006)
- Doxycycline Hyclate 20 Mg Twice Daily - Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea - This study has been completed (Current: 23 Nov 2006)
- Doxycycline - A Clinical Trial to Determine the Effects of 40 Mg Doxycycline Versus a Placebo Control for the Treatment of Rosacea - This study has been completed (Current: 23 Nov 2006)
- Investigational Topical Agent - Topical Agent for Treatment of Red Skin - This study is currently recruiting patients (Current: 23 Nov 2006)
- MetroGel® (metronidazole gel), 1.0% 1x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
- Vehicle control, 2x/day - A Phase II, Randomized Study of ACZONE (Dapsone) Gel, 5% for Papulopustular Rosacea. - This study has been completed (Current: 23 Nov 2006)
- Zinc Sulfate or placebo - Zinc Sulfate in the Treatment of Rosacea: A Randomized, Controlled Trial - This study is currently recruiting patients (Current: 23 Nov 2006)
The trial data on this page has been sourced from
Handling acne begins with basic skin care techniques and understanding your treatment options.
The first step to clearing up acne is getting the facts. Learn the facts about acne-prone skin and how best to treat it.
Health insurance is important to everyone, especially people with chronic conditions like Crohn's disease and ulcerative colitis. Tune in to...
Sleep is necessary to feel refreshed, but now we know sleep actually impacts the way the body functions. Sleeping poorly can affect how often you get...
See full list of 4 related videos
» Next page: External links relating to Rosacea
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: